
Before this decision, the only vaccine that had been approved for use in very young children was the Sinopharm vaccine which was approved for ages 3-17, with Pfizer shots being available to children above 12.
“The results of clinical studies indicated that the vaccine is safe and has given a strong immune response to children between the age of 5 and 11 years,” the statement said of the Pfizer shots.
It also said people with chronic diseases who previously received Pfizer-BioNtech or the Russia-developed Sputnik vaccinations can now get a third booster shot.
Previously the government had been giving booster shots to people fully vaccinated with Sinopharm vaccines.